News

News
Share this article
15 July 2016

Fundacíon Botín encourages its researchers to use the European Lead Factory

Fundacíon Botín encourages its researchers to use the European Lead Factory

News
Share this article
13 June 2016

On the fast track to beat neglected tropical diseases

The European Lead Factory has lowered the hurdles for non-profit drug discovery programmes in the area of neglected tropical diseases (NTDs). 

News
Share this article
06 June 2016

First Polish drug target programme selected

A drug discovery programme involving an epigenetic target is the first drug target programme from Poland selected by the European Lead Factory. The selected drug target is a part of the oncology project developed by Selvita within its epigenetics platform.

News
Share this article
10 May 2016

Bridging the Innovation Gap

The European Lead Factory is described as ‘bridging the innovation gap’ in a recent Careers Feature in the journal Nature. 

News
Share this article
03 May 2016

First Spanish programme selected

The first drug target programme from Spain has been selected by The European Lead Factory. It involves an epigenetic target against cancer that is being investigated by the Center for Applied Medical Research (CIMA) at the University of Navarra.

News
Share this article
22 April 2016

Combinatorial library optimization process

The public part of Joint European Compound Library (JECL) is built using many small libraries (typically about 500 compounds per library) based around innovative scaffolds.

News
Share this article
20 April 2016

Thirty partners - four years together in the lead

European Lead Factory General Assembly 2016 in Leiden, The Netherlands

News
Share this article
01 April 2016

Nature Reviews Drug Discovery: ‘European Lead Factory hits its stride’

Today, Nature Reviews Drug Discovery published a News & Analysis article: ‘European Lead Factory hits its stride.’

News
Share this article
23 March 2016

IHL phase passes the thousand compounds mark for public programmes

Public target programmes that have received a promising Qualified Hit List (QHL) have the possibility to continue their collaboration with the European Lead Factory with the aim of producing an Improved Hit List (IHL). 

News
Share this article
27 January 2016

European Lead Factory has commenced a drug screening campaign for one of Effecta Pharma’s Dengue viral targets

"We are excited we can continue our initial collaboration with the EU Lead Factory and its European Screening Centre researchers in Oss, Oxford and  Newhouse, which has yielded a screenable assay for one of the critical Dengue virus proteins. Having the EU Lead Factory as part of our concerted effort to generate preclinical candidates for Dengue  is welcome support for Effecta and the patients suffering from this disease”, Effecta’s Directors Helmuth van Es and Paul Edwards said.

Pages